期刊文献+

全反式维甲酸对白血病HL-60细胞株GPI-PLD基因表达的影响

Study on Impact of All-transretinoic Acid on the Expression of GPI-PLD in Leukemia Cell HL-60
原文传递
导出
摘要 目的研究用分化诱导剂全反式维甲酸(ATRA)培养HL-60细胞株后GPI-PLD的表达变化,以初步探讨该酶在全反式维甲酸(ATRA)作用下的变化及其与白血病细胞生长增殖的关系。方法用ATRA处理HL-60细胞后,以胎盘碱性磷酸酶为底物,定量检测GPI-PLD活性;RT-PCR法确定GPI-PLD mRNA表达水平;MTT检测细胞增殖;流式细胞仪检测细胞周期。结果加入全反式维甲酸培养后,HL-60细胞株中GPI-PLD表达量和活性增加。流式细胞仪检测显示细胞阻滞在G2/M期;MTT实验检测显示ATRA处理后HL-60细胞株增殖生长受到抑制。结论加ATRA处理后HL-60细胞株增殖生长受到抑制,可能与GPI-PLD表达量显著增加有关。 Objective To investigate the expression of glycosylphosphatidyl inositol specific phospholipase D(GPI-PLD) in leukemia cell HL-60 after ATRA added to the culture medium,to find out the relative function of GPI-PLD in the course of leukemia generating and developing,as well as to make out the influence of ATRA on GPI-PLD. Methods RT-PCR was used to detect the expression level of GPI-PLD mRNA in HL-60 cell line after ATRA added to the culture medium.GPI-PLD activities were analyzed quantitatively by TX-114 partition with GPI anchored placental alkaline phosphatase(PLAP) as a substrate.MTT was used to detect the proliferation in each group,and the cell circle of leukemia cell induced by ATRA was determined by the flow cytometer. Results After ATRA added to the culture medium,the mRNA expression and activities of GPI-PLD in HL-60 cell line were significantly increased.The proliferative capacity was significantly decreased and the cell cycle was arrested in G2/M phase. Conclusions The ATRA can induce expression of GPI-PLD and GPI-PLD probably has contact with leukemias generating and developing.
出处 《实用预防医学》 CAS 2011年第11期2055-2057,共3页 Practical Preventive Medicine
关键词 糖基化磷脂酰肌醇特异性磷脂酶D(GPI-PLD) 白血病 HL-60细胞株 全反式维甲酸 Glycosylphosphatidyl inositol specific phospholipase D Leukemia HL-60 cell line All-transretinoic acid
  • 相关文献

参考文献13

  • 1叶红,但自力,唐望先.全反式维甲酸抗肿瘤作用的研究进展[J].肿瘤防治研究,2005,32(12):800-802. 被引量:11
  • 2Han Qing-Long. New results for delay dependent stability of linear systems with time-varying delay. International Journal of System Science, 2002,33:213-228
  • 3Fridman E. New Lyapunov-Krasovskii functionals for stability of linear retarded and neutral type systems. System & Control Letters, 2001,43: 309-319
  • 4Zhang Xi-Ping, Tsiotras P, Knospe C. Stability analysis of LPV timed systems. International Journal of Control,2002,75:538-558
  • 5Lien C-H, Yu K-W, Hsieh J-G. Stability conditions for a class of neutral systems with multiple time delays. Journal of Math. Analysis Applications, 2000,245: 20-27
  • 6Fan K K, Lien C H, Hsieh J G. Asymptotic stability for a class of neutral systems with discrete and distributed time delays. Journal of Optimization theory and applications, 2002,114 : 705 - 716
  • 7Hale J K, Verduyn Lunel S M. Introduction of Functional Differential Equations. New York: Springer,1993
  • 8Xu Sheng-Yuan, Dooren P V, Stefan R, Lam J. Robust stability and stabilization for singular systems with state delay and parameter uncertainty. IEEE Transactions on Automatic Control, 2002,47:1122 - 1128
  • 9Park J H, Won S. Asymptotic stability of neutral systems with multiple delays. Journalof Optimization Theory and Applications, 1999,103:183-200
  • 10Watanabe K, Bianco C, Strizzi L, et al. Growth factor induction of Cripto- 1 shedding by glycosylphphatidylinositol - phospholipase D and enhancement of endothelial cell migration .[J ]. J Biol Chem, 2007, 282(43) :31643 - 31655.

二级参考文献30

  • 1Kostrikis LG. Spectral genotyping of human alleles[ J ]. Science,1998, 279:1228-1336.
  • 2Marras SA, Kramer FR, Tyagi S. Multiple detection of single-nucleotide variations using molecular beacons[J]. Genet Anal,1999,14:151-157.
  • 3Eckert C, Landt O, Taube T, et al, Potential of light cycle technology for quantification of minimal residual disease[J]. Leukemia, 2000,14:316-324.
  • 4Treon SP, Mitsiades C, Mitsiades N, et al . Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-Cell malignancies [ J ]. J Immunother, 2001, 24(3) : 263-271.
  • 5Jurianz K, Ziegler S, Donin N, et al. K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lyses by complement[J]. Int J Cancer, 2001, 93(6) : 848-854.
  • 6Schmitt CA, Schwaeble W, Wittig Bm, et al. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46(MCP) , CD55 (DAF) , and CD59 in gastrointestinal tumors[ J ]. Eur J Cancer, 1999, 35 : 117-124.
  • 7Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction [ J ]. Proc Natl Acad Sci USA, 1989,86:9717-9721.
  • 8Huang Y, Boskovic G, Niles RM. Retinoic acid-induced AP-1 transcriptional activity regulates B16 mouse melanoma growth inhibition and differentiation[J]. J Cell Physiol,2003, 194(2) :162-170.
  • 9Liu F, Qi HL, Chen HL. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23 H1 in human hepatocarcinoma cells [J]. J Cancer Res Clin Oncol,2000, 126(2) :85-90.
  • 10Yoon WH, Song IS, Lee BH,et al. Differential regulation of vimentin mRNA by 12-O-tetradecanoylphorbol 13-acetate and all-trans-retinoic acid correlates with motility of Hep 3B human hepatocellular carcinoma cells[J]. Cancer Lett,2004, 203(1):99-105.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部